Of note, in prostate cancer, LINC00861 was closely associated with T cells regulatory, macrophages M2 and mast cells resting as well as a series of immune checkpoints, including PD1, PD-L1, and CTLA4. Here, CTLA4 is linked to prostate carcinoma.